AG-024104 is a CDK inhibitor with K i values of 2.3 nM ( CDK1 /cyclinB), 1.8 nM ( CDK2 /cyclinA), and 0.67 nM ( CDK4 /cyclinD). AG-024104 functionally inhibits kinase activity of CDK1 /cyclinB, CDK2 /cyclinA, and CDK4 /cyclinD. AG-024104 serves as a negative control for peripheral leukocyte toxicity studies in preclinical development.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.